Indo-Bangla Pharmaceuticals Limited (DSE: IBP)
Bangladesh
· Delayed Price · Currency is BDT 9.70
-0.10 (-1.02%)
At close: Jan 23, 2025
DSE: IBP Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jul '22 Jul 1, 2022 | Jul '21 Jul 1, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Net Income | -44.98 | -40.98 | 8.41 | 25.17 | 134.73 | 156.24 | Upgrade
|
| Depreciation & Amortization | 26.14 | 28.54 | 38.36 | 39.13 | 35.9 | 28.9 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | -0.7 | - | 0.77 | - | Upgrade
|
| Other Operating Activities | 3.2 | 14.32 | 21.4 | -1.54 | 7.69 | 25.11 | Upgrade
|
| Change in Accounts Receivable | 21.39 | 21.39 | -4.72 | 26.82 | -19.67 | -46.04 | Upgrade
|
| Change in Inventory | 17.02 | 17.02 | 2.47 | 21.01 | -11.8 | 12.58 | Upgrade
|
| Change in Accounts Payable | 0.02 | 0.02 | -0.09 | 0.31 | 0.25 | -5.74 | Upgrade
|
| Change in Other Net Operating Assets | -6.55 | -6.55 | 7.82 | -23.61 | 3.17 | 4.47 | Upgrade
|
| Operating Cash Flow | 16.25 | 33.77 | 72.95 | 87.28 | 151.02 | 175.53 | Upgrade
|
| Operating Cash Flow Growth | -79.96% | -53.71% | -16.42% | -42.20% | -13.96% | 5.24% | Upgrade
|
| Capital Expenditures | -5.57 | -10.13 | -30.03 | -39.68 | -200.41 | -309 | Upgrade
|
| Investing Cash Flow | -5.57 | -10.13 | -43.47 | -54.18 | -200.41 | -309 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 84.94 | - | Upgrade
|
| Total Debt Issued | 2.82 | - | - | - | 84.94 | - | Upgrade
|
| Short-Term Debt Repaid | - | -19.41 | -31.75 | -9.59 | - | - | Upgrade
|
| Total Debt Repaid | -18.09 | -19.41 | -31.75 | -9.59 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -15.27 | -19.41 | -31.75 | -9.59 | 84.94 | - | Upgrade
|
| Common Dividends Paid | -0.29 | -0.29 | -10.4 | -24.79 | -26.91 | -13.27 | Upgrade
|
| Other Financing Activities | -4.52 | -4.85 | -4.72 | -5.63 | - | - | Upgrade
|
| Financing Cash Flow | -20.08 | -24.55 | -46.87 | -40 | 58.03 | -13.27 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0 | -0 | - | 0 | 13.11 | - | Upgrade
|
| Net Cash Flow | -9.39 | -0.91 | -17.39 | -6.9 | 21.75 | -146.74 | Upgrade
|
| Free Cash Flow | 10.68 | 23.64 | 42.92 | 47.6 | -49.39 | -133.47 | Upgrade
|
| Free Cash Flow Growth | -80.22% | -44.92% | -9.84% | - | - | - | Upgrade
|
| Free Cash Flow Margin | 8.97% | 13.38% | 11.46% | 9.82% | -6.31% | -15.41% | Upgrade
|
| Free Cash Flow Per Share | 0.09 | 0.20 | 0.37 | 0.41 | -0.43 | -1.17 | Upgrade
|
| Cash Interest Paid | 4.52 | 4.85 | 4.72 | 5.63 | - | - | Upgrade
|
| Cash Income Tax Paid | 3.43 | 3.6 | - | 13.72 | 16.35 | 35.65 | Upgrade
|
| Levered Free Cash Flow | 18.8 | 29.92 | 15.65 | 75.07 | -74.57 | -157.1 | Upgrade
|
| Unlevered Free Cash Flow | 21.42 | 32.67 | 18.92 | 78.12 | -72.19 | -157.1 | Upgrade
|
| Change in Net Working Capital | -18.68 | -29.11 | 7.34 | -56.3 | 15.99 | 9.39 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.